title: Prenatal programming by testosterone of hypothalamic metabolic control neurones in the ewe.
abstract: Ewes treated prenatally with testosterone develop metabolic deficits, including insulin resistance, in addition to reproductive dysfunctions that collectively mimic polycystic ovarian syndrome (PCOS), a common endocrine disease in women. We hypothesised that metabolic deficits associated with prenatal testosterone excess involve alterations in arcuate nucleus (ARC) neurones that contain either agouti-related peptide (AgRP) or pro-opiomelanocortin (POMC). Characterisation of these neurones in the ewe showed that immunoreactive AgRP and POMC neurones were present in separate populations in the ARC, that AgRP and POMC neurones co-expressed either neuropeptide Y or cocaine- and amphetamine-regulated transcript, respectively, and that each population had a high degree of co-localisation with androgen receptors. Examination of the effect of prenatal testosterone exposure on the number of AgRP and POMC neurones in adult ewes showed that prenatal testosterone excess significantly increased the number of AgRP but not POMC neurones compared to controls; this increase was restricted to the middle division of the ARC, was mimicked by prenatal treatment with dihydrotestosterone, a non-aromatisable androgen, and was blocked by co-treatment of prenatal testosterone with the anti-androgen, flutamide. The density of AgRP fibre immunoreactivity in the preoptic area, paraventricular nucleus, lateral hypothalamus and dorsomedial hypothalamic nucleus was also increased by prenatal testosterone exposure. Thus, ewes that were exposed to androgens during foetal life showed alterations in the number of AgRP-immunoreactive neurones and the density of fibre immunoreactivity in their projection areas, suggestive of permanent prenatal programming of metabolic circuitry that may, in turn, contribute to insulin resistance and an increased risk of obesity in this model of PCOS.
authors.affiliation: Department of Anatomy and Cell Biology, The University of Western Ontario, London, Canada.
authors.forename: K M
authors.initials: KM
authors.lastname: Sheppard
authors.forename: V
authors.initials: V
authors.lastname: Padmanabhan
authors.forename: L M
authors.initials: LM
authors.lastname: Coolen
authors.forename: M N
authors.initials: MN
authors.lastname: Lehman
mesh_terms: D054369:Agouti-Related Protein / Q000378:metabolism; D000818:Animals; D001111:Arcuate Nucleus of Hypothalamus / Q000166:cytology / Q000378:metabolism; D004734:Energy Metabolism / Q000502:physiology*; D005260:Female; D005333:Fetus / Q000033:anatomy & histology / Q000187:drug effects* / Q000502:physiology; D006801:Humans; D007031:Hypothalamus / Q000166:cytology* / Q000378:metabolism*; D009474:Neurons / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D011085:Polycystic Ovary Syndrome / Q000503:physiopathology; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects; D011333:Pro-Opiomelanocortin / Q000378:metabolism; D012756:Sheep; D013739:Testosterone / Q000494:pharmacology*
chemical_list: D054369:Agouti-Related Protein; D013739:Testosterone; D011333:Pro-Opiomelanocortin